Margaret McGlynn, Former President of Global Vaccines at Merck, Joins IAVI Board

The International AIDS Vaccine Initiative (IAVI) announces the appointment of Margaret McGlynn, former President of Global Vaccines and Anti-infectives at Merck, to its board of directors. IAVI's President and Chief Executive Officer, Seth Berkley said that IAVI "expects that her business acumen, her hands-on experience in the vaccine industry and HIV marketplace, and the depth of her knowledge about health, public policy and development issues will prove invaluable to the board."  The full announcement is attached below.